Comments
Agappe Diagnostics Ltd, a leading diagnostic reagents and equipment manufacturer, has announced a tie-up with Japanese multinational Toyobo Co Ltd for technology licensing to manufacture early cancer detection devices.
Thomas John, Managing Director, Agappe, told reporters here that the manufacture of the equipment and its reagents would begin at Agappe’s manufacturing facility at Pattimattom near here.
The instrument is easy to operate and provides fast and highly specific results at a reduced cost. The aim is to provide everyone across the country accurate result at right time for proper diagnosis, he said.
Toyobo company officials explained the technological advancements offered by the new equipment. The machine is highly compact and designed using smart card based calibration technology for error free testing.
The unit is expected to start production within 18 months, and Agappe is planning to update the system to enable cardiac and sepsis testing in later stage.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.